Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 1.4 Market Analysis by Type 1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Paracetamol 1.4.3 Ibuprofen 1.4.4 Aspirin 1.4.5 Naproxen 1.4.6 Others 1.5 Market by Application 1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026) 2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions 2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020) 2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy 2.3.6 Primary Interviews with Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size 3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020) 3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020) 3.1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio 3.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019 3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served 3.4 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service 3.5 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020) 4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026) 5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application (2015-2026) 5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020) 6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020) 7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 8 China 8.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020) 8.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 8.4 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020) 9.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 9.4 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 10.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 11 India 11.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020) 11.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 11.4 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 12.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020) 12.3 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 12.4 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Novartis 13.1.1 Novartis Company Details 13.1.2 Novartis Business Overview and Its Total Revenue 13.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)) 13.1.5 Novartis Recent Development 13.2 Pfizer 13.2.1 Pfizer Company Details 13.2.2 Pfizer Business Overview and Its Total Revenue 13.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.2.5 Pfizer Recent Development 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Company Details 13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue 13.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.3.5 Boehringer Ingelheim Recent Development 13.4 Teva Pharmaceutical 13.4.1 Teva Pharmaceutical Company Details 13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.4.5 Teva Pharmaceutical Recent Development 13.5 Hospira 13.5.1 Hospira Company Details 13.5.2 Hospira Business Overview and Its Total Revenue 13.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.5.5 Hospira Recent Development 13.6 Lonza Group 13.6.1 Lonza Group Company Details 13.6.2 Lonza Group Business Overview and Its Total Revenue 13.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.6.5 Lonza Group Recent Development 13.7 Mylan 13.7.1 Mylan Company Details 13.7.2 Mylan Business Overview and Its Total Revenue 13.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.7.5 Mylan Recent Development 13.8 Aurobindo Pharma 13.8.1 Aurobindo Pharma Company Details 13.8.2 Aurobindo Pharma Business Overview and Its Total Revenue 13.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.8.5 Aurobindo Pharma Recent Development 13.9 Dr. Reddy's Laboratories 13.9.1 Dr. Reddy's Laboratories Company Details 13.9.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue 13.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.9.5 Dr. Reddy's Laboratories Recent Development 13.10 Actavis 13.10.1 Actavis Company Details 13.10.2 Actavis Business Overview and Its Total Revenue 13.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.10.5 Actavis Recent Development 13.11 Wuxi Apptec 10.11.1 Wuxi Apptec Company Details 10.11.2 Wuxi Apptec Business Overview and Its Total Revenue 10.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 10.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 10.11.5 Wuxi Apptec Recent Development 13.12 Zhejiang NHU 10.12.1 Zhejiang NHU Company Details 10.12.2 Zhejiang NHU Business Overview and Its Total Revenue 10.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 10.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 10.12.5 Zhejiang NHU Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Market Segments Table 2. Key Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Table 3. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Paracetamol Table 6. Key Players of Ibuprofen Table 7. Key Players of Aspirin Table 8. Key Players of Naproxen Table 9. Key Players of Others Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2015-2020) Table 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy Table 20. Main Points Interviewed from Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Table 21. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2015-2020) (Million US$) Table 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2015-2020) Table 23. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019) Table 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service Table 27. Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2015-2020) Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026) Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2015-2020) Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 34. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2021-2026) Table 35. North America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 36. North America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 37. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 38. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 39. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 40. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 41. Europe Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 43. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 44. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 45. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 46. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 47. China Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 48. China Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 49. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 50. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 51. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 52. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 53. Japan Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 55. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 56. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 57. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 58. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 61. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 63. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 65. India Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 66. India Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 67. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 68. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 69. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 70. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 71. Central & South America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020) Table 73. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020) Table 75. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020) Table 77. Novartis Company Details Table 78. Novartis Business Overview Table 79. Novartis Product Table 80. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 81. Novartis Recent Development Table 82. Pfizer Company Details Table 83. Pfizer Business Overview Table 84. Pfizer Product Table 85. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 86. Pfizer Recent Development Table 87. Boehringer Ingelheim Company Details Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Product Table 90. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 91. Boehringer Ingelheim Recent Development Table 92. Teva Pharmaceutical Company Details Table 93. Teva Pharmaceutical Business Overview Table 94. Teva Pharmaceutical Product Table 95. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 96. Teva Pharmaceutical Recent Development Table 97. Hospira Company Details Table 98. Hospira Business Overview Table 99. Hospira Product Table 100. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 101. Hospira Recent Development Table 102. Lonza Group Company Details Table 103. Lonza Group Business Overview Table 104. Lonza Group Product Table 105. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 106. Lonza Group Recent Development Table 107. Mylan Company Details Table 108. Mylan Business Overview Table 109. Mylan Product Table 110. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 111. Mylan Recent Development Table 112. Aurobindo Pharma Business Overview Table 113. Aurobindo Pharma Product Table 114. Aurobindo Pharma Company Details Table 115. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 116. Aurobindo Pharma Recent Development Table 117. Dr. Reddy's Laboratories Company Details Table 118. Dr. Reddy's Laboratories Business Overview Table 119. Dr. Reddy's Laboratories Product Table 120. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 121. Dr. Reddy's Laboratories Recent Development Table 122. Actavis Company Details Table 123. Actavis Business Overview Table 124. Actavis Product Table 125. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 126. Actavis Recent Development Table 127. Wuxi Apptec Company Details Table 128. Wuxi Apptec Business Overview Table 129. Wuxi Apptec Product Table 130. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 131. Wuxi Apptec Recent Development Table 132. Zhejiang NHU Company Details Table 133. Zhejiang NHU Business Overview Table 134. Zhejiang NHU Product Table 135. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$) Table 136. Zhejiang NHU Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2026 Figure 2. Paracetamol Features Figure 3. Ibuprofen Features Figure 4. Aspirin Features Figure 5. Naproxen Features Figure 6. Others Features Figure 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026 Figure 8. Hospital Pharmacies Case Studies Figure 9. Retail Pharmacies Case Studies Figure 10. Online Pharmacies Case Studies Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2026 Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2019 Figure 17. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019 Figure 19. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 30. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 32. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 34. Hospira Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 36. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 40. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 42. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 44. Actavis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 46. Wuxi Apptec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 48. Zhejiang NHU Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Novartis Pfizer Boehringer Ingelheim Teva Pharmaceutical Hospira Lonza Group Mylan Aurobindo Pharma Dr. Reddy's Laboratories Actavis Wuxi Apptec Zhejiang NHU